×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Mechanism: TREM2 Mechanism Hub
mechanism
5,099 words
KG: TREM2
2026-03-31
kind:mechanism
section:mechanisms
state:published
evidence:strong
Contents
TREM2 Mechanism Hub
⚙
Mechanism Info
Name
TREM2 Mechanism Hub
Summary
Page for TREM2 Mechanism Hub
Key Genes/Proteins
APOE
Related Diseases
ALZHEIMERS
,
Als
,
Alzheimer
,
Inflammation
,
Neuroinflammation
Linked Hypotheses
54 hypotheses
Knowledge Graph
Related Hypotheses (30)
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
Score: 0.64
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.61
TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener
Score: 0.61
TREM2-CSF1R Cross-Talk in Microglial Metabolic Reprogramming
Score: 0.59
TREM2-SIRT1 Metabolic Senescence Circuit in Microglial Aging
Score: 0.59
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.59
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.58
Microglial-Mediated Tau Clearance Dysfunction via TREM2 Sign
Score: 0.53
TREM2-Mediated Microglial Dysfunction Disrupts Perivascular
Score: 0.53
Microglial TREM2 downregulation impairs damage-associated re
Score: 0.51
Disease-Associated Microglia Metabolic Reprogramming
Score: 0.50
TREM2-APOE4 Co-targeting — Simultaneous Correction of Lipid
Score: 0.49
Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammatio
Score: 0.49
Oligodendrocyte Remyelination Enhancement
Score: 0.47
Peripheral-Central Immune Decoupling Therapy
Score: 0.46
TREM2-Mediated Microglial Checkpoint Therapy
Score: 0.46
Stage-Selective TREM2 Agonism — Boosting DAM Phagocytosis in
Score: 0.46
Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in
Score: 0.46
TREM2 R47H Variant Correction — AAV-Mediated Rescue of Commo
Score: 0.45
TREM2-Dependent Microglial Surveillance Controls AQP4-Mediat
Score: 0.45
TREM2-Mediated Microglial Dysfunction Disrupts Oligodendrocy
Score: 0.45
Soluble TREM2 (sTREM2) as Therapeutic Mimic — Decoupling Pha
Score: 0.45
TREM2-DAP12 Signalosome Enhancement — Boosting PI3K-AKT-mTOR
Score: 0.45
TREM2 Antagonism in Late-Stage Tauopathy — Reducing Neuroinf
Score: 0.44
Astrocytic-Mediated Tau Clearance Dysfunction via TREM2 Sign
Score: 0.43
TREM2-P2RY12 Balance Restoration Therapy
Score: 0.37
TREM2-Dependent Microglial Senescence Transition
Score: 0.69
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52
Orexin-Microglia Modulation Therapy
Score: 0.49
APOE-TREM2 Interaction Modulation
Score: 0.48
Show 25 more
Related Analyses (30)
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · completed
Neuroinflammation and microglial priming in early Alzheimer'
neurodegeneration · archived
Neuroinflammation and microglial priming in early AD
neurodegeneration · completed
TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · archived
Mechanistic validation of SEA-AD differential expression hyp
neurodegeneration · failed
Do these mechanistic hypotheses explain layer-specific synap
neurodegeneration · failed
Do these mechanistic hypotheses from the SEA-AD Atlas bundle
neurodegeneration · failed
What are the optimal temporal windows for TREM2 inhibition v
neurodegeneration · failed
What are the optimal timing windows for TREM2 inhibition vs
neurodegeneration · failed
Does SYK activation provide neuroprotection or exacerbate ne
neurodegeneration · failed
Can TREM2 receptor switching from agonism to antagonism be a
neurodegeneration · failed
What are the optimal timing windows for TREM2 agonism vs ant
neurodegeneration · failed
Can biased TREM2 agonists selectively activate DAP12-SYK-PI3
molecular biology · failed
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · failed
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · archived
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Show 25 more
Related Experiments (30)
TREM2 KO amyloid pathology study
validation · completed · Score: 0.75
TREM2 KO amyloid pathology study
validation · completed · Score: 0.75
TREM2 KO amyloid pathology study
validation · in_progress · Score: 0.75
TREM2 KO amyloid pathology study
validation · completed · Score: 0.75
TREM2 KO amyloid pathology study
validation · completed · Score: 0.75
TREM2 KO amyloid pathology study
validation · in_progress · Score: 0.75
TREM2 KO amyloid pathology study
validation · completed · Score: 0.75
s:** - GPR32 knockout in microglia should worsen neuroinflam
falsification · proposed · Score: 0.46
Proposed experiment from debate on Synaptic pruning by micro
falsification · proposed · Score: 0.46
Proposed experiment from debate on Synaptic pruning by micro
falsification · proposed · Score: 0.46
s:** - Compare tau strain spreading in EXT1/EXT2 conditional
falsification · proposed · Score: 0.46
Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti
clinical · proposed · Score: 0.46
Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy
validation · proposed · Score: 0.46
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.46
Experiment: Autoimmune Hypothesis Testing in AD
clinical · proposed · Score: 0.46
Blood Biomarker vs Tau PET for Treatment Monitoring
clinical · proposed · Score: 0.46
CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.46
DLB Cognitive Fluctuation Mechanism Experiment
clinical · proposed · Score: 0.46
Genetic Risk Modifiers in DLB Phenotype
clinical · proposed · Score: 0.46
DLB Treatment Response Biomarkers — Predicting Cholinesteras
clinical · proposed · Score: 0.46
FTD Microglia Role: Protective vs Destructive Mechanism Stud
validation · proposed · Score: 0.46
FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation
clinical · proposed · Score: 0.46
Microglial Aging and Immune Memory in Neurodegeneration — Tr
validation · proposed · Score: 0.46
Microglial Contributions to Huntington's Disease Pathogenesi
validation · proposed · Score: 0.46
Mixed Pathology Effects on Parkinson's Disease Progression a
clinical · proposed · Score: 0.46
Non-Motor Symptom Progression in Parkinson's Disease — Mecha
clinical · proposed · Score: 0.46
Prodromal Parkinson's Disease Biomarker Development — Early
clinical · proposed · Score: 0.46
Progranulin Replacement Therapy for FTD — Vector Development
clinical · proposed · Score: 0.46
PSP and CBS Biomarker Validation Study
clinical · proposed · Score: 0.46
Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo
clinical · proposed · Score: 0.46
Show 25 more
See Also (5)
ACSL4 Gene - Acyl-CoA Synthetase Long Chain Family Memb
gene · KG edge: activates
ACE Gene
gene · KG edge: associated_with
ABI3 Gene
gene · KG edge: associated_with
ABCA1 - ATP-Binding Cassette Transporter A1
gene · KG edge: activates
ABCA7 (Redirect)
redirect · KG edge: associated_with
Knowledge Graph (12 edges)
TREM2
associated_with
neurodegeneration
TREM2
implicated_in
neurodegeneration
TREM2
co_discussed
ALOX12
TREM2
co_discussed
P2RY12
TREM2
co_discussed
C1Q
TREM2
co_discussed
C1QA
TREM2
co_discussed
CX3CR1
TREM2
co_discussed
ANXA1
TREM2
co_discussed
CLOCK
TREM2
co_discussed
CRH